Furthermore, donor NK cells expressing KIR2DS1 have been linked to the better control of GvHD [90], and donors carrying the KIR Bx haplotype were similarly associated with a decreased risk of GvHD. This evidence concerns the gene KIR3DL1 and graft versus host disease.